A Dose of Reality with Charles Spence8 Juli 2024

Building powerful relationships ft. Val Nassiri, previous VP of Medical Affairs at ITM and AAA.

In this episode Charles discusses with Val, the previous VP of Medical Affairs at ITM and AAA, the importance of genuine relationship-building and personal presence in the field of Medical Affairs and pharmaceutical industry leadership.

Val emphasizes that success in this field isn't just about scientific knowledge or achieving immediate results. Instead, it's about how you behave as a person, your ability to be present and attentive in interactions, and your capacity to build long-term relationships based on trust and transparency.

He sums this up nicely with the quote: "Attention is the rarest and purest form of generosity."

Here's what you're in for:

03:00 Starting a Career in Nuclear Pharmacy

07:07 Moving to Medical Affairs

10:03 Making Connections in Medical Affairs

18:38 Difficulties and Skills Needed in Medical Affairs

23:25 Building a Good Medical Affairs Team

28:22 Leadership Growth: Pros and Cons

29:19 Handling Growth and People in Organizations

31:15 Keeping Staff in Expanding Companies

36:42 When and How to Hire the Right People

45:15 Overused Words in Job Ads

51:19 Wrapping Up and Last Ideas

About Val Nassiri

Dr. Val Nassiri, MBA, PharmD, Head of Medical Affairs U.S., leads the Medical Affairs team at ITM. He works on strategic plans for radiopharmaceutical projects. Before this, Val was the Head of Medical Affairs at AAA, a Novartis company. He also worked as Senior Director at Daiichi Sankyo. There, he formed teams and made partnerships to help with research. His aim was to help patients live longer. Val graduated from the Bernard J. Dunn School of Pharmacy in Virginia.

Connect with Val:

LinkedIn: https://www.linkedin.com/in/val-nassiri-pharmd-mba-84b7961/

About Charles

Charles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry.

He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea), and also spent years doing diabetes research. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with Charles:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://www.discera-search.com/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(74)

Eliot Forster, CEO at Levicept on 30 Years in Pharma, Running a Six-Person Biotech, and the Future of European Drug Development

In this episode, I talked with Eliot Forster, CEO of Levicept, a neurophysiologist-turned biotech veteran with 30+ years of experience across Big Pharma and a series of CEO roles. We get into clinical...

7 Sep 45min

Michael Zaiac, Medical Affairs Lead for Oncology at Daiichi Sankyo on 30 Years of Hiring Lessons, The ADC Wave, and Building Teams in a Fast-Moving Pipeline

In this episode, I talked with Michael Zaiac, Medical Affairs Lead for Oncology across Europe and Canada at Daiichi Sankyo — a trained surgical oncologist who walked away from the operating table, mov...

24 Aug 39min

Juho Jalkanen, CEO at Faron Pharmaceuticals on From Surgeon to CEO, Rethinking Boards, and Fighting for the Right Science

In this episode, I talked with Dr. Juho Jalkanen, CEO of Faron Pharmaceuticals — a publicly listed Finnish biotech building novel immunotherapies for blood cancers. Juho's path is unlike most you'll h...

10 Aug 37min

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Juni 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Maj 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Maj 33min

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Maj 28min

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like ...

30 Mars 42min